Australian CRO Avance Clinical said that Australia’s fast regulatory approval environment, key opinion leader expertise and high-quality clinical research sites, as well as the attractive 40% Government rebate on clinical trial spend, means Avance is uniquely positioned to deliver rapid results for urgent COVID-19
More
The Almac Group, a CDMO serving the pharmaceutical and biotech sectors globally,
Novotech, the largest biotech CRO in Asia Pacific, says the region has
Nantes, France, Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of clinical batches of
More
Australian CRO Avance Clinical said that Australia’s fast regulatory approval environment, key opinion leader expertise and high-quality clinical research sites,
MoreNovotech, the largest biotech CRO in Asia Pacific, says the region has had a record year for clinical trials in
MoreThe Almac Group, a CDMO serving the pharmaceutical and biotech sectors globally, is expanding its Edinburgh Technopole facility to allow
More
